The Hong Kong Investment Corporation (HKIC), an investment firm wholly owned by the city-state’s government, has invested in the Beijing-based bio-computing startup BioMap, to supercharge the city’s life sciences development via strategic direct investments.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
